| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy RV Lalla, J Bowen, A Barasch, L Elting, J Epstein, DM Keefe, DB McGuire, ... Cancer 120 (10), 1453-1461, 2014 | 1275 | 2014 |
| Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients W Barcellini, B Fattizzo, A Zaninoni, T Radice, I Nichele, E Di Bona, ... Blood, The Journal of the American Society of Hematology 124 (19), 2930-2936, 2014 | 401 | 2014 |
| Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ... Blood 108 (3), 853-861, 2006 | 242 | 2006 |
| Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases M Federico, U Vitolo, PL Zinzani, T Chisesi, V Clo, G Bellesi, M Magagnoli, ... Blood, The Journal of the American Society of Hematology 95 (3), 783-789, 2000 | 238 | 2000 |
| Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 … EN Oliva, C Alati, V Santini, A Poloni, A Molteni, P Niscola, F Salvi, ... The Lancet Haematology 4 (3), e127-e136, 2017 | 187 | 2017 |
| Mucositis in patients with hematologic malignancies: an overview P Niscola, C Romani, L Cupelli, L Scaramucci, A Tendas, T Dentamaro, ... Haematologica 92 (2), 222-231, 2007 | 186 | 2007 |
| Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic … MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ... Journal of Clinical Oncology 31 (21), 2671-2677, 2013 | 184 | 2013 |
| Systematic review of amifostine for the management of oral mucositis in cancer patients O Nicolatou-Galitis, T Sarri, J Bowen, M Di Palma, VE Kouloulias, ... Supportive Care in Cancer 21, 357-364, 2013 | 163 | 2013 |
| Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients O Nicolatou-Galitis, T Sarri, J Bowen, M Di Palma, VE Kouloulias, ... Supportive Care in Cancer 21, 3179-3189, 2013 | 151 | 2013 |
| Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the I talian network on secondary leukemias L Fianchi, L Pagano, A Piciocchi, A Candoni, G Gaidano, M Breccia, ... American journal of hematology 90 (5), E80-E85, 2015 | 128 | 2015 |
| Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome MAA Spiriti, R Latagliata, P Niscola, A Cortelezzi, M Francesconi, ... Annals of Hematology 84, 167-176, 2005 | 122 | 2005 |
| The use of major analgesics in patients with renal dysfunction P Niscola, L Scaramucci, G Vischini, M Giovannini, M Ferrannini, P Massa, ... Current drug targets 11 (6), 752-758, 2010 | 99 | 2010 |
| Pain syndromes in sickle cell disease: an update P Niscola, F Sorrentino, L Scaramucci, P De Fabritiis, P Cianciulli Pain Medicine 10 (3), 470-480, 2009 | 93 | 2009 |
| Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study F Efficace, G Gaidano, M Breccia, MT Voso, F Cottone, E Angelucci, ... The Lancet Oncology 16 (15), 1506-1514, 2015 | 90 | 2015 |
| Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes F Efficace, G Gaidano, M Breccia, M Criscuolo, F Cottone, G Caocci, ... British journal of haematology 168 (3), 361-370, 2015 | 81 | 2015 |
| Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS) GA Abel, F Efficace, RJ Buckstein, S Tinsley, JG Jurcic, Y Martins, ... Haematologica 101 (6), 781, 2016 | 80 | 2016 |
| Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy P Niscola, MI Del Principe, L Maurillo, A Venditti, F Buccisano, D Piccioni, ... Leukemia 19 (10), 1840-1841, 2005 | 69 | 2005 |
| Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience C Cartoni, P Niscola, M Breccia, G Brunetti, GM D'Elia, M Giovannini, ... Leukemia & lymphoma 50 (3), 387-391, 2009 | 66 | 2009 |
| TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge? M Molica, C Mazzone, P Niscola, P De Fabritiis Frontiers in oncology 10, 610820, 2021 | 65 | 2021 |
| Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies GA Brunetti, A Tendas, E Meloni, D Mancini, P Maggiore, L Scaramucci, ... Annals of hematology 90, 1233-1235, 2011 | 63 | 2011 |
paolo de fabritiisuniroma2.it의 이메일 확인됨
